ROCKWELL MEDICAL, INC. (RMTI) Share-based Payment Arrangement, Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rockwell Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Rockwell Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $251 K, a 30.1% increase year-over-year.
  • Rockwell Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $990 K, a 44.1% increase year-over-year.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $932 K, a 196% increase from 2022.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $315 K, a 66.6% decline from 2021.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $943 K, a 98.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $990 K $251 K +$58 K +30.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $932 K $218 K -$2 K -0.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $934 K $212 K +$36 K +20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $898 K $309 K +$211 K +215% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $687 K $193 K +$372 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $315 K $220 K -$165 K -42.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $480 K $176 K -$185 K -51.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $665 K $98 K -$335 K -77.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1 M -$179 K +$57 K +24.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $943 K $385 K -$366 K -48.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.31 M $361 K +$111 K +44.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.2 M $433 K +$1.89 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$696 K -$236 K -$1.17 M -125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $475 K $751 K -$305 K -28.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $780 K $250 K -$627 K -71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.41 M -$1.46 M -$2.96 M -197% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $4.37 M $935 K -$582 K -38.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $4.95 M $1.06 M -$905 K -46.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $5.86 M $877 K +$262 K +42.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.59 M $1.5 M +$136 K +9.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.46 M $1.52 M +$1.07 M +240% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $4.39 M $1.96 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $615 K -$1.02 M -62.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.37 M -$746 K -35.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $446 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $1.64 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.11 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.